Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea · Delayed Price · Currency is KRW
16,210
-450 (-2.70%)
At close: Jan 29, 2026
KOSDAQ:014950 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 |
|---|
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 58,875 | 55,857 | 51,229 |
| - | -0 | - |
| 58,875 | 55,857 | 51,229 |
| 14.93% | 9.04% | - |
| 16,904 | 17,119 | 17,359 |
| 41,971 | 38,738 | 33,870 |
| 35,714 | 32,612 | 28,847 |
| 2,123 | 1,943 | 1,757 |
Amortization of Goodwill & Intangibles | 5.02 | 25 | 56.12 |
| 261.52 | 302.34 | 287.89 |
| 38,247 | 35,060 | 31,073 |
| 3,725 | 3,678 | 2,796 |
| -9.1 | -12.26 | -18.53 |
Interest & Investment Income | 78.3 | 186.69 | 198.16 |
Currency Exchange Gain (Loss) | 1.7 | 1.75 | 1.36 |
Other Non Operating Income (Expenses) | 190.61 | 213.21 | 147.23 |
EBT Excluding Unusual Items | 3,986 | 4,067 | 3,124 |
Gain (Loss) on Sale of Investments | 308.4 | 300.14 | 298.32 |
Gain (Loss) on Sale of Assets | 2.77 | 9.5 | 0.07 |
| - | -23.8 | - |
| 4,297 | 4,353 | 3,423 |
| 1,030 | 830.99 | 453.53 |
| 3,267 | 3,522 | 2,969 |
| 3,267 | 3,522 | 2,969 |
| 10.04% | 18.62% | - |
Shares Outstanding (Basic) | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 |
| 1.61% | 0.15% | - |
| 458.09 | 501.00 | 423.00 |
| 458.09 | 501.00 | 423.00 |
| 8.29% | 18.44% | - |
| 2,055 | 3,543 | 874.05 |
| 288.12 | 503.91 | 124.52 |
| 71.29% | 69.35% | 66.11% |
| 6.33% | 6.59% | 5.46% |
| 5.55% | 6.31% | 5.80% |
| 3.49% | 6.34% | 1.71% |
| 5,111 | 5,029 | 4,074 |
| 8.68% | 9.00% | 7.95% |
| 1,386 | 1,351 | 1,278 |
| 3,725 | 3,678 | 2,796 |
| 6.33% | 6.59% | 5.46% |
| 23.97% | 19.09% | 13.25% |
| - | 565.36 | 753.43 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.